| Literature DB >> 30863473 |
S Fatima Lakha1, Peri Ballantyne2, Hanan Badr3, Mubina Agboatwala4, Angela Mailis1,5, Peter Pennefather1,6.
Abstract
An increasing proportion of the global chronic pain population is managed through services delivered by specialized pain clinics in global cities. This paper describes the results of a survey of pain clinic leaders in three global cities on barriers influencing chronic noncancer pain (CNCP) management provided by those clinics. It demonstrates a pragmatic qualitative approach for characterizing how the global city location of the clinic influences those results. A cross-sectional prospective survey design was used, and data were analyzed using quantitative and qualitative content analysis. Key informants were pain clinicians (n = 4 women and 8 men) responsible for outputs of specialized pain clinics in academic hospital settings in three global cities: Toronto, Kuwait, and Karachi. Krippendorff's thematic clustering technique was used to identify the repetitive themes in the data. All but one of the key informants had their primary pain training from Europe or North America. In Kuwait and Karachi, pain specialists were anesthesiologists and provided CNCP management services independently. In Toronto, pain clinic leaders were part of some form of the multidisciplinary team. Using the results of a question that asked informants to list their top three barriers, ten themes were identified. These themes were artificially organized in three thematic domains: infrastructure, clinical services, and education. In parallel, 31 predefined barriers identified from the literature were scored. The results showed variation in perception of barriers that not only depended on the clinic location but also demonstrated shared experiences across thematic domains. This study demonstrates a simple methodology for informing global and local efforts to improve access to and implementation of CNCP services globally.Entities:
Mesh:
Year: 2019 PMID: 30863473 PMCID: PMC6377973 DOI: 10.1155/2019/3091309
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1Example of dendrogram.
Principal barriers in pain programs.
| Domain | Themes | Toronto | Kuwait | Karachi |
|---|---|---|---|---|
| Infrastructure | (1) Lack of general resources | x | x | x |
| (2) Lack of human resources | x | x | x | |
| (3) Obstacles in hospital systems | x | x | x | |
|
| ||||
| Clinical services | (4) System barriers | — | x | x |
| (5) Patients issues | x | x | ||
| (6) Lack of communication/collaboration among providers | x | — | — | |
|
| ||||
| Education | (7) Shortage of systematic pain management education program | x | — | — |
| (8) Lack of pain management knowledge among pain clinic staff | x | x | x | |
| (9) Lack of pain management knowledge by general physicians | — | x | x | |
| (10) Lack of education of patient population | — | x | x | |
x: at least one key informant from the city indicated by the column heading reported a barrier that could be assigned to the barriers theme row.
Perception of Barrier for Managing CNCP.
| Toronto | Kuwait | Karachi | |
|---|---|---|---|
|
| |||
| (i) Psychological and social support services | 3.25 | 3.75 | 3.75 |
| (ii) Lack of access to interventions (blocks, spinal stimulators, etc.) | 2.25 | 2.25 | 2.75 |
| (iii) Lack of time and resources to address noncancer pain | 3 | 3.25 | 2.75 |
| (iv) Access to assessment of patients with CNCP | 1.5 | 1.5 | 2.75 |
| (v) Clinic too far or inconvenient for patients' to travel to | 3 | 1.75 | 3.25 |
| (vi) High cost of medications and treatments | 3 | 0.75 | 4 |
| (vii) Lack of access to wide range neuropathic adjuvant medications (e.g., gabapentin, pregabalin, duloxetine) | 2.25 | 1.5 | 1.75 |
| (viii) Access to wide range of opioids | 1 | 3 | 3 |
| (ix) Regulation of opioids by Narcotics Bureau, Dept. of Health | 0 | 3.25 | 3.25 |
| (x) Excessive regulation of opioids in pharmacy | 0 | 3 | 3.5 |
| (xi) Waiting list to see physicians/specialists | 3 | 2.5 | 2.75 |
| (xii) Regulatory barriers to effective pain management | 1.5 | 2.75 | 2.75 |
|
| |||
|
| |||
| (i) Coordination of care, particularly acute to chronic transition | 3.25 | 3.5 | 3 |
| (ii) Patient and family fear that reporting pain will exclude a patient from clinical trials or treatment | 1 | 1.5 | 2 |
| (iii) Patients' reluctance to take opioids | 2 | 2.25 | 3 |
| (iv) Legal and regulatory sanctions for opioid use | 0.5 | 2 | 3.5 |
| (v) Inadequate reimbursement for providers | 1.75 | 0.5 | 2.25 |
| (vi) Patient and family failure to mention pain to providers | 1 | 1 | 2.5 |
| (vii) Religion (e.g., male physicians cannot see female patients, etc.) | 1 | 0.5 | 2.5 |
| (viii) Cultural barriers to accepting taking pain medications | 1 | 2 | 2.5 |
| (ix) Cultural barriers (e.g., male patients do not complain as they think pain is a sign of weakness) | 1 | 1.25 | 2.25 |
| (x) Physicians' reluctance to prescribe opioids | 0.5 | 3.75 | 3 |
| (xi) Patient's fear drugs will lose their effectiveness | 2.25 | 3.25 | 3 |
| (xii) Patient adherence to treatment regimens | 2.75 | 3.25 | 3 |
| (xiii) Lack of public awareness about the presence of pain clinic | 2.25 | 3.5 | 3.75 |
| (xiv) Cognitive impairment hindering assessment | 1.75 | 2 | 2.5 |
|
| |||
|
| |||
| (i) Inadequate CNCP management training and education of staff | 3 | 1 | 3 |
| (ii) A priority on curing noncancer pain over managing | 3.75 | 2.25 | 3 |
| (iii) Knowledge about available resources | 2.5 | 3.25 | 3 |
| (iv) Awareness of other physicians about pain clinic benefits for referral purposes | 1.75 | 3.5 | 3.75 |
| (v) Inadequate staff knowledge of pain management | 2 | 3.25 | 3.25 |
Likert scale compression: 0–2 (mild); >2<3 (moderate); 3–4 (severe); values indicate mean score with N = 4 from each studied.
| (D) BARRIERS |
|
|
| What are the 3 principal barriers for you in the pain program? |
| (1) |
| (2) |
| (3) |
| Comments: |
| 0 | ++ | +++ | ++++ | |
|
| ||||
|
| ||||
| Psychological and social support services | ||||
| Lack of access to interventions (blocks, spinal stimulators etc.) | ||||
| Lack of time and resources to address noncancer pain | ||||
| Access to assessment of patients with chronic noncancer pain | ||||
| Clinic too far or inconvenient for patient to travel to | ||||
| High cost of medications and treatments | ||||
| Lack of access to wide range neuropathic adjuvant medications (e.g., Gabapentin, pregabalin, duloxetine) | ||||
| Access to wide range of opioids | ||||
| Excessive regulation of opioids in Narcotics Bureau, Department of Health | ||||
| Excessive regulation of opioids in pharmacy | ||||
| Waiting list to see physicians/specialists | ||||
| Regulatory barriers to effective pain management | ||||
|
| ||||
|
| ||||
| Coordination of care, particularly during transition from acute to chronic | ||||
| Patient and family fear that reporting pain will exclude patient from clinical trials or treatment | ||||
| Patients' reluctance to take opioids | ||||
| Legal and regulatory sanctions for opioid use | ||||
| Inadequate reimbursement for providers | ||||
| Patient and family failure to mention pain to providers | ||||
| Religious barrier (e.g., Male physicians cannot see female patients etc.) | ||||
| Cultural barrier for pain medications | ||||
| Cultural barriers (e.g., Male patients do not complain as they think pain is sign of weakness) | ||||
| Religious barriers (e.g., Male physicians cannot see female patients etc.) | ||||
| Physicians' reluctance to prescribe opioids | ||||
| Patient's fear drugs will lose their effectiveness | ||||
| Patient adherence to treatment regimens | ||||
| Lack of awareness among patients and families about presence of pain clinic | ||||
| Cognitive impairment hindering assessment | ||||
|
| ||||
|
| ||||
| Inadequate noncancer pain management training and education | ||||
| A priority on curing noncancer pain over managing | ||||
| Awareness of other physicians about pain clinic benefits for referral purposes | ||||
| Knowledge about available resources | ||||
| Inadequate staff knowledge of pain management | ||||